Last reviewed · How we verify

Allergan — Portfolio Competitive Intelligence Brief

Allergan pipeline: 58 marketed, 0 filed, 35 Phase 3, 54 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

58 marketed 0 filed 35 Phase 3 54 Phase 2 24 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Botox ONABOTULINUMTOXINA marketed Acetylcholine Release Inhibitor [EPC] SNAP-25 Neuroscience 2010-01-01
GoodSense Eye Drops Advanced Relief Moisturizer DEXTRAN marketed Plasma Volume Expander [EPC] Ophthalmology 1978-01-01
bimatoprost ophthalmic solution 0.03% bimatoprost ophthalmic solution 0.03% marketed
Dexamethasone intravitreal implant Dexamethasone intravitreal implant marketed
latanoprost 0.005% latanoprost 0.005% marketed
Botulinum Toxin Type A 150kDa Botulinum Toxin Type A 150kDa marketed
AGN-190584 AGN-190584 marketed Other
Bystolic nebivolol marketed 5-hydroxytryptamine receptor 1A, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor Cardiovascular
travoprost 0.004% travoprost 0.004% marketed
IV Placebo (Saline) IV Placebo (Saline) marketed
Lubricant Eye Drops (Optive™) Lubricant Eye Drops (Optive™) marketed Artificial tear / Lubricant Ophthalmology
Oxymetazoline HCL Cream 1.0% Oxymetazoline HCL Cream 1.0% marketed Alpha-1 adrenergic agonist Alpha-1 adrenergic receptor Dermatology

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Pfizer · 8 shared drug classes
  2. Merck Sharp & Dohme LLC · 7 shared drug classes
  3. GlaxoSmithKline · 7 shared drug classes
  4. Bausch & Lomb Incorporated · 5 shared drug classes
  5. AbbVie · 5 shared drug classes
  6. Novartis · 5 shared drug classes
  7. AstraZeneca · 4 shared drug classes
  8. Assistance Publique - Hôpitaux de Paris · 4 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Allergan:

Cite this brief

Drug Landscape (2026). Allergan — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/allergan. Accessed 2026-05-13.

Related